e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Bronchoscopic treatment of COPD and asthma: where are we going?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: A feasibility and safety study, of bronchoscopic hot saline ablation (BHSA) of emphysematous lung. A different emphysema therapy
D. Stav, N. Natiff, I. Shpirer (beer Yaakov, Israel)
Source:
Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Session:
Bronchoscopic treatment of COPD and asthma: where are we going?
Session type:
Thematic Poster Session
Number:
2280
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Stav, N. Natiff, I. Shpirer (beer Yaakov, Israel). LATE-BREAKING ABSTRACT: A feasibility and safety study, of bronchoscopic hot saline ablation (BHSA) of emphysematous lung. A different emphysema therapy. Eur Respir J 2013; 42: Suppl. 57, 2280
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Preliminary results of study of bronchoscopic hot saline ablation (BHSA) treatment, in emphysematous lung disease
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
Bronchoscopic lung volume reduction with coils (BLVR-Coils) for treatment of patients with severe heterogeneous emphysema and bilaterally incomplete fissures. Its effectiveness in everyday endoscopic practice
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Endoscopic lung volume reduction (ELVR) in COPD: A comparison between two endobronchial valves systems
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015
Survival benefit from successful bronchoscopic lung volume reduction with endobronchial valves - A 10 year follow up study
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Safety and efficacy of emphysematous lung sealant (ELS) therapy for advanced emphysema out to 2 years
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
Endobronchial microbiological colonisation in stable COPD patients with severe emphysema undergoing endoscopic lung volume reduction.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Severe heterogeneous emphysema treated unilaterally with endobronchial coils in patients with bilaterally incomplete fissures. Aiming for long lasting endoscopic lung volume reduction (ELVR); is effectiveness sustained at one year follow-up?
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014
Effectiveness and complications of endobronchial coil treatment for lung volume reduction (LVRC) in patients with severe heterogeneous emphysema and bilateral incomplete fissures
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014
Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013
Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012
Endobronchial valve placement as a treatment of persistent pulmonary air leak
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR)
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015
Correlation between patients' background and the therapeutic effect of BLVR using EMV (endobronchial Miyazawa valve)
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013
CT predictors of response to endobronchial valve lung reduction treatment: Comparison with Chartis pulmonary assessment system
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014
Long-term outcomes in 35 patients with emphysema after endoscopic lung volume reduction (ELVR) with valves
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept